Invest in your career with a Madrona-funded company.

A-Alpha Bio

aalphabio.com

A-Alpha Bio is a biotechnology company that leverages synthetic biology and machine learning to measure, predict, and engineer protein-protein interactions. Their experimental platform, Alpha Seq, allows for the rapid and quantitative measurement of millions of protein-protein binding affinities simultaneously, while their computational platform, Alpha Bind, predicts binding strength from sequence using the world’s largest protein-protein interaction database. A-Alpha Bio collaborates with leading pharmaceutical companies to inform the discovery and development of novel therapeutics, positioning itself as a key player in therapeutic discovery and optimization.